Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$1.22 - $2.57 $56,744 - $119,535
46,512 Added 23610.15%
46,709 $95,000
Q1 2022

May 12, 2022

SELL
$1.16 - $1.83 $18,768 - $29,609
-16,180 Reduced 98.8%
197 $0
Q4 2021

Feb 14, 2022

SELL
$1.63 - $3.41 $24,761 - $51,801
-15,191 Reduced 48.12%
16,377 $27,000
Q3 2021

Nov 15, 2021

BUY
$3.11 - $4.75 $98,176 - $149,948
31,568 New
31,568 $101,000
Q2 2021

Aug 16, 2021

SELL
$4.94 - $9.43 $16,647 - $31,779
-3,370 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$1.43 - $15.48 $50,789 - $549,803
-35,517 Reduced 91.33%
3,370 $28,000
Q4 2020

Feb 16, 2021

BUY
$0.73 - $3.22 $28,387 - $125,216
38,887 New
38,887 $73,000
Q3 2020

Nov 16, 2020

SELL
$0.73 - $1.04 $7,099 - $10,115
-9,726 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$0.8 - $2.1 $4,936 - $12,957
6,170 Added 173.51%
9,726 $10,000
Q1 2020

May 15, 2020

BUY
$1.0 - $6.05 $3,556 - $21,513
3,556 New
3,556 $4,000

About SECOND SIGHT MEDICAL PRODUCTS INC


  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.